Dr. Jesse Panger is a highly experienced organic chemist with a specialization in drug formulations, organic synthesis, and analytical chemistry. He has extensive experience performing analytical testing of a wide array of substances, interpreting data, and detailing those findings in reports. These reports have been used by the Food and Drug Administration (FDA) and the pharmaceutical industry to determine the viability of a drug in the setting of a Good Manufacturing Practices/Good Laboratory Practices (GMP/GLP) environment. In the case of failed quality checks for active pharmaceutical ingredients (APIs), Dr. Panger has performed extensive investigations including root cause analysis, outlined corrective and preventive actions, and developed new protocols to overcome product failures. Other areas of specialization include Compound Characterization, Chemical Analysis, Poison/Contaminants, Scanning Electron Microscopy (SEM), and Polymeric Evaluations.
Areas of Expertise
Publications
- Enantioselective Inter- and Intramolecular Sulfenofunctionalization of Unactivated Cyclic and (Z)-Alkenes, ACS Catal. 2022, 12, 7377 – 7385., January 0001
- Catalytic, Enantioselective Sulfenofunctionalization of Alkenes: Development and Recent Advances, Angew. Chem. Int. Ed. 2020, 59, 19796 – 19819., January 2020
- Enantioselective, Lewis Base-Catalyzed Carbosulfenylation of Alkenylboronates by 1,2- Boronate Migration, J. Am. Chem. Soc., 2018, 140, 46, 15621 – 15625, January 2018